Menu Search
Equities

Koninklijke Philips NV

PHG:NYQ

Koninklijke Philips NV

Actions
Health CareHealth Care Equipment & Services
  • Price (USD)54.40
  • Today's Change-0.80 / -1.45%
  • Shares traded532.74k
  • 1 Year change+30.26%
  • Beta0.8890
Data delayed at least 15 minutes, as of Feb 27 2021 00:00 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in EURIncome statement in EURView more

Year on year Koninklijke Philips NV had no change in net income (1.19bn). Revenues were also unchanged at 19.54bn.
Gross margin44.95%
Net profit margin6.17%
Operating margin7.89%
Return on assets4.41%
Return on equity9.78%
Return on investment6.04%
More ▼

Cash flow in EURView more

In 2020, Koninklijke Philips NV increased its cash reserves by 126.39%, or 1.80bn. The company earned 2.69bn from its operations for a Cash Flow Margin of 13.77%. In addition the company generated 483.00m cash from financing while 1.32bn was spent on investing.
Cash flow per share3.56
Price/Cash flow per share15.02
Book value per share15.83
Tangible book value per share1.15
More ▼

Balance sheet in EURView more

Koninklijke Philips NV has a Debt to Total Capital ratio of 36.81%, a lower figure than the previous year's 39.21%.
Current ratio1.45
Quick ratio1.06
Total debt/total equity0.5842
Total debt/total capital0.3681
More ▼

Growth rates in EUR

Year on year, growth in dividends per share fell -100.00% while earnings per share excluding extraordinary items rose 2.53%. Additionally, five year annualized earnings per share growth ranks above the industry average relative to its peers.
Div yield(5 year avg)1.62%
Div growth rate (5 year)--
Payout ratio (TTM)63.32%
EPS growth(5 years)53.37
EPS (TTM) vs
TTM 1 year ago		0.322
More ▼
Refinitiv, an LSEG business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.